These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7103443)

  • 1. Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans.
    Laskin OL; Longstreth JA; Saral R; de Miranda P; Keeney R; Lietman PS
    Antimicrob Agents Chemother; 1982 Mar; 21(3):393-8. PubMed ID: 7103443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose pharmacokinetics of acyclovir.
    Spector SA; Connor JD; Hintz M; Quinn RP; Blum MR; Keeney RE
    Antimicrob Agents Chemother; 1981 Apr; 19(4):608-12. PubMed ID: 7247383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans.
    Laskin OL; de Miranda P; King DH; Page DA; Longstreth JA; Rocco L; Lietman PS
    Antimicrob Agents Chemother; 1982 May; 21(5):804-7. PubMed ID: 7103460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir kinetics in end-stage renal disease.
    Laskin OL; Longstreth JA; Whelton A; Rocco L; Lietman PS; Krasny HC; Keeney RE
    Clin Pharmacol Ther; 1982 May; 31(5):594-601. PubMed ID: 7075109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir clinical pharmacology. An overview.
    Lietman PS
    Am J Med; 1982 Jul; 73(1A):193-6. PubMed ID: 7048912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of radioactive acyclovir in humans.
    de Miranda P; Good SS; Krasny HC; Connor JD; Laskin OL; Lietman PS
    Am J Med; 1982 Jul; 73(1A):215-20. PubMed ID: 7102704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.
    Whitley RJ; Blum MR; Barton N; de Miranda P
    Am J Med; 1982 Jul; 73(1A):165-71. PubMed ID: 7102700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of intravenous radioactive acyclovir.
    de Miranda P; Good SS; Laskin OL; Krasny HC; Connor JD; Lietman PS
    Clin Pharmacol Ther; 1981 Nov; 30(5):662-72. PubMed ID: 7297024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir kinetics after intravenous infusion.
    de Miranda P; Whitley RJ; Blum MR; Keeney RE; Barton N; Cocchetto DM; Good S; Hemstreet GP; Kirk LE; Page DA; Elion GB
    Clin Pharmacol Ther; 1979 Dec; 26(6):718-28. PubMed ID: 227639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of acyclovir pharmacokinetic disposition in adults and children.
    Blum MR; Liao SH; de Miranda P
    Am J Med; 1982 Jul; 73(1A):186-92. PubMed ID: 7048911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous intravenous infusion.
    Spector SA; Hintz M; Wyborny C; Connor JD; Keeney RE; Liao S
    Am J Med; 1982 Jul; 73(1A):275-80. PubMed ID: 6285719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclovir concentrations and tolerance during repetitive administration for 18 days.
    Laskin OL; Saral R; Burns WH; Angelopulos CM; Lietman PS
    Am J Med; 1982 Jul; 73(1A):221-4. PubMed ID: 7048913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tolerance to and pharmacokinetics of penciclovir (BRL 39,123A), a novel antiherpes agent, administered by intravenous infusion to healthy subjects.
    Fowles SE; Pierce DM; Prince WT; Staniforth D
    Eur J Clin Pharmacol; 1992; 43(5):513-6. PubMed ID: 1336464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure.
    Krasny HC; Liao SH; de Miranda P; Laskin OL; Whelton A; Lietman PS
    Am J Med; 1982 Jul; 73(1A):202-4. PubMed ID: 7102703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient.
    Yang HH; Hsiao YP; Shih HC; Yang JH
    Int J Dermatol; 2007 Aug; 46(8):883-4. PubMed ID: 17651180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal failure on the pharmacokinetics of acyclovir.
    Laskin OL; Longstreth JA; Whelton A; Krasny HC; Keeney RE; Rocco L; Lietman PS
    Am J Med; 1982 Jul; 73(1A):197-201. PubMed ID: 7102702
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic disposition of acyclovir in the guinea pig, rabbit, and monkey.
    Good SS; de Miranda P
    Am J Med; 1982 Jul; 73(1A):91-5. PubMed ID: 7102713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis.
    Van Dyke RB; Connor JD; Wyborny C; Hintz M; Keeney RE
    Am J Med; 1982 Jul; 73(1A):172-5. PubMed ID: 7102701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of acyclovir in the dog.
    Krasny HC; de Miranda P; Blum MR; Elion GB
    J Pharmacol Exp Ther; 1981 Feb; 216(2):281-8. PubMed ID: 7463350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pharmacokinetics of acyclovir (an antiviral agent) following rapid intravenous injection.
    Brigden D; Bye A; Fowle AS; Rogers H
    J Antimicrob Chemother; 1981 Apr; 7(4):399-404. PubMed ID: 7251524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.